Get started
Author

Virginia Ann Rhodes

Observed names: V A Rhodes, V.A. Rhodes, Virginia Rhodes
OpenAlex ID: A5065437652
Phase I study of docetaxel dose escalation in combination with fixed weekly gemcitabine in patients with advanced malignancies.
1998 · C H Spiridonidis, L R Laufman, et al. · Journal of Clinical Oncology · 72
Phase I Study of Doxil® and Vinorelbine in Patients with Advanced Malignancies
2004 · Leslie R. Laufman, C. Harris Spiridonidis, et al. · Cancer Investigation · 5
Daily times four vinorelbine plus cisplatin in advanced non-small-cell lung cancer: A phase II trial of a novel schedule
1999 · C.H. Spiridonidis, L.R. Laufman, et al. · Annals of Oncology · 4
GEMINI-NSCLC: Multiomics and single-cell spatial profiling to benchmark, back-translate, and build digital twins of IO response.
2026 · Vincent Perez, Candice Gurbatri, et al. · Journal of Clinical Oncology
GEMINI-BREAST: Evaluating minimal residual disease (MRD) through longitudinal circulating tumor DNA (ctDNA) profiling in breast malignancies.
2026 · Matthew E. Campbell, Lauren Lopez, et al. · Journal of Clinical Oncology
GEMINI-NSCLC study: Integrated longitudinal multi-omic biomarker profiling study of non-small cell lung cancer (NSCLC) patients.
2025 · Douglas C. Palmer, Virginia Ann Rhodes, et al. · Journal of Clinical Oncology
PDF
Sparking shifts in STEM: Facilitating equitable change through workshops on emerging and understudied research questions
2024 · Joan Herbers, Heather Metcalf, et al.
PDF
Works count: 7
Citation count: 81
H-index: 3
I10-index: 1
Year
Topic
Type